scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00702-011-0587-8 |
P698 | PubMed publication ID | 21290151 |
P50 | author | Hiroshi Ichinose | Q39066113 |
P2093 | author name string | Hirofumi Tokuoka | |
Kazuko Hasegawa | |||
Teruo Yokoyama | |||
Shoko Koshiba | |||
Emiko Horiuchi | |||
P2860 | cites work | Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice | Q24293070 |
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology | Q28131833 | ||
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease | Q28292932 | ||
Hydroxylase Cofactor Activity in Cerebrospinal Fluid of Normal Subjects and Patients with Parkinson's Disease | Q28326297 | ||
Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson's disease mutation G2019S | Q28589899 | ||
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. | Q30483115 | ||
Progression of dopaminergic dysfunction in a LRRK2 kindred: a multitracer PET study | Q33668068 | ||
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease | Q33754793 | ||
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. | Q34118222 | ||
(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease | Q35452165 | ||
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes | Q37243261 | ||
Concentrations of neopterin and biopterin in the cerebrospinal fluid of patients with Parkinson's disease | Q44610902 | ||
Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease | Q46525821 | ||
PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation | Q46635617 | ||
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology | Q47621759 | ||
Tetrahydrobiopterin in Striatum: Localization in Dopamine Nerve Terminals and Role in Catecholamine Synthesis | Q49156811 | ||
Significance of CSF total neopterin and biopterin in inflammatory neurological diseases | Q67558756 | ||
Depression and Parkinson's disease: possible role of serotonergic mechanisms | Q68988930 | ||
Analysis of reduced forms of biopterin in biological tissues and fluids | Q71136634 | ||
Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease | Q74624173 | ||
P433 | issue | 6 | |
P304 | page(s) | 899-903 | |
P577 | publication date | 2011-02-03 | |
P1433 | published in | Journal of Neural Transmission | Q15750921 |
P1476 | title | Biopterin levels in the cerebrospinal fluid of patients with PARK8 (I2020T) | |
P478 | volume | 118 |
Q48137257 | Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease |
Q38271572 | Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease. |
Q92017939 | What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson's Disease Patients and Healthy Subjects with Parkinson's-Associated LRRK2 Mutations? |
Search more.